Projects per year
Abstract
Acrolein is a highly reactive α,β-unsaturated aldehyde produced endogenously through lipid peroxidation and enzymatic metabolism and exogenously via environmental exposures. Acrolein covalently adducts to DNA and proteins, leading to oxidative stress, mitochondrial dysfunction, and inflammation, including innate immune response activation via natural antibodies. Acrolein is difficult to measure in biological systems, but its covalent products can be measured reliably. Therapeutically, nucleophilic small molecules that scavenge acrolein such as hydralazine, phenelzine, dimercaprol, carnosine, and N-acetylcysteine (NAC) have shown neuroprotective effects in animal models of multiple sclerosis, Parkinson's disease, spinal cord injury, and traumatic brain injury. These effects include preserved membrane and mitochondrial integrity, reduced inflammation, reduced pain, and improved motor, sensory, and cognitive outcomes. Alternative strategies that enhance clearance or inhibit production of acrolein show promise but face limitations. Acrolein is a key pathophysiological mediator and a viable therapeutic target in central nervous system trauma and neurodegenerative diseases.
| Original language | English |
|---|---|
| Pages (from-to) | 107-133 |
| Number of pages | 27 |
| Journal | Annual Review of Biomedical Engineering |
| Volume | 28 |
| DOIs | |
| Publication status | Published - May 2026 |
Funding
| Funders | Funder number |
|---|---|
| NHMRC National Health and Medical Research Council | 572580, 403967 |
Fingerprint
Dive into the research topics of 'Multimodal Toxicity of Acrolein and Associated Therapeutic Strategies in Central Nervous System Trauma and Disease'. Together they form a unique fingerprint.Projects
- 2 Finished
-
Mechanisms of Epithelial Damage by the Noxious Smoke Constituent Acrolein
Burcham, P. (Investigator 01) & Henry, P. (Investigator 02)
NHMRC National Health and Medical Research Council
31/12/08 → 31/12/13
Project: Research
-
403697: Pharmacological Strategy for Blocking Lung Cell Damage by Toxic Smoke Constituents
Burcham, P. (Chief Investigator) & Pyke, S. (Chief Investigator)
1/01/06 → 31/12/08
Project: Research
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver